查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
PTSD（创伤后应激障碍）治疗市场：按药物类别、给药途径、年龄组、分销渠道、地区 - 规模、份额、前景和机会分析，2022-2030 年
市场调查报告书
商品编码
1181763

PTSD（创伤后应激障碍）治疗市场：按药物类别、给药途径、年龄组、分销渠道、地区 - 规模、份额、前景和机会分析，2022-2030 年

Post-traumatic Stress Disorder Treatment Market, by Drug Class, by Route of Administration, by Age Group, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 183 Pages | 商品交期: 2-3个工作天内

价格
简介目录

PTSD（创伤后应激障碍）是一种精神疾病，可能由于自然灾害、生活危机、交通事故和性虐待而发生在人身上。 PTSD 症状可能会在 3 个月后甚至一年后出现。 许多患有 PTSD 的人会出现侵入性记忆、迴避、思维的负面变化以及情绪和身体反应的变化等症状。 例如，亲人的突然死亡可能会导致某些人出现 PTSD。 患有创伤后应激障碍的人有更高的危险感。 据美国国家创伤后应激障碍中心称，估计约有 15% 的越南战争退伍军人和 12% 的海湾战争退伍军人患有创伤后应激障碍。 据美国精神病学协会称，女性患创伤后应激障碍的可能性是男性的两倍。 PTSD（创伤后应激障碍）的常用处方药包括抗抑郁药、舍曲林、氟西汀和帕罗西汀。

市场动态

主要市场参与者对 PTSD（创伤后应激障碍）治疗的研发活动的增加将在预测期内推动全球 PTSD（创伤后应激障碍）治疗市场的增长。预计 例如，2021 年 12 月，製药公司 Jazz Pharmaceuticals plc. 宣布已招募首位患者参加 2 期临床试验。 JZP150 是一种高选择性脂肪酸□胺水解□ (FAAH) 抑製剂，旨在解决 PTSD（恐惧消退及其锚定受损）的根本原因以及患者的焦虑、失眠和噩梦等相关症状。

这项研究的主要特点

  • 本报告使用 2021 年作为预测期的基准年：2022-2030 年全球创伤后应激障碍 (PTSD) 治疗市场、市场规模（百万美元）和復合年增长率 (CAGR) (%)进行了详细分析。
  • 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
  • 它还提供了有关市场驱动因素和推动因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
  • 全球 PTSD（创伤后应激障碍）治疗市场的主要参与者根据公司概况、业绩、产品组合、地域分布、分销战略、关键发展和战略等参数进行分析。
  • 本次调查涵盖的主要公司包括 Jazz Pharmaceuticals plc.、Madrigal Mental Care、Allergan PLC、Otsuka Pharmaceutical Co., Ltd.、apex laboratories Pvt. Ltd.、H. Lundbeck A/S (Lundbeck)、Neurovation Labs、 Inc.、Eli Lilly and Company、GlaxoSmithKline PLC、Sun Pharmaceuticals Pvt Ltd、Bristol-Myers Squibb、Johnson and Johnson、Pfizer Inc.、Aurobindo Inc.、Amneal Pharmaceuticals LLC、Teva Pharmaceuticals Industries Ltd. 和 Mylan Pharmaceuticals（Viatris Inc.） )
  • 这份报告中的见解将使企业营销人员和高管能够就未来的产品发布、政府举措、技术升级、市场扩张和营销策略做出明智的决策。将是
  • 《全球 PTSD（创伤后应激障碍）疗法市场报告》是一份综合报告，涵盖了该行业的各种利益，包括投资者、产品製造商、分销商、供应商、研究和咨询公司、新进入者和金融分析师。给利益相关者。
  • 利益相关者可以通过用于分析全球 PTSD（创伤后应激障碍）治疗市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按药物类别
    • 按给药途径划分的市场概况
    • 市场概况：按年龄组
    • 市场概况：按分销渠道
    • 市场概况：按地区
  • 连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

  • 市场动态
    • 司机
    • 约束因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 主要发展状况
  • 产品批准
  • 合伙/合併/收购
  • 监管状况
  • 害虫分析
  • 波特五力分析
  • 流行病学
  • 可靠的流水线分析

第 4 章 PTSD（创伤后应激障碍）治疗的全球市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 总体影响
  • COVID-19 对市场的影响

第 5 章全球创伤后应激障碍 (PTSD) 治疗市场，按药物类别，2017-2030

  • 2022 年和 2030 年市场份额分析 (%)
  • 2017-2030 年同比增长率分析
  • 抗抑郁药
  • 抗焦虑药
  • 抗高血压药
  • 单胺氧化□ (MAO)
  • 抗精神病药或第二代抗精神病药 (SGO)
  • β受体阻滞剂
  • 其他（苯二氮卓类药物，其他）

第 6 章全球创伤后应激障碍 (PTSD) 治疗市场（按给药途径）：2017-2030

  • 口服剂
  • 父母代理人
  • 鼻剂

第 7 章按年龄组划分的全球创伤后应激障碍 (PTSD) 治疗市场：2017-2030

  • 儿科
  • 成人
  • 年老

第 8 章全球创伤后应激障碍 (PTSD) 治疗市场（按分销渠道），2017-2030

  • 医院药房
  • 零售药房
  • 在线药店

第 9 章按地区分列的全球创伤后应激障碍 (PTSD) 治疗市场，2017-2030

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 其他亚太地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中非
  • 南非

第10章竞争格局

  • 热图分析
  • 市场份额分析
  • 公司简介
    • Jazz Pharmaceuticals plc.
    • Madrigal Mental Care
    • Allergan PLC
    • Otsuka Pharmaceutical Co., Ltd.
    • apex laboratories Pvt. Ltd.
    • H. Lundbeck A/S（Lundbeck）
    • Neurovation Labs, Inc.
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Sun Pharmaceuticals Pvt Ltd
    • Bristol-Myers Squibb
    • Johnson and Johnson
    • Pfizer Inc.
    • Aurobindo Inc.
    • Amneal Pharmaceuticals LLC
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan Pharmaceuticals（Viatris Inc.）

第 11 章章节

  • 参考资料
  • 调查方法介绍
  • 关于出版商
简介目录
Product Code: CMI4433

Post-traumatic stress disorder (PTSD) is a psychiatric condition that may occur in people who have witnessed a traumatic shock like natural disaster, a life threatening event, car accident, sexual abuse etc. Symptoms of PTSD may generate after three months or even after a year. Most of the patients suffering from PTSD show symptoms like intrusive memories, avoidance, negative changes in thinking and changes in emotional and physical reactions. For instance, sudden death of a loved one may cause PTSD in some people. People with PTSD have heightened sense of danger. According to the U.S. National centre for PTSD, it is estimated that about 15% of the veterans of Vietnam War and 12% of gulf war veterans have PTSD. According to American Psychiatric Association, women are twice likely to get PTSD as compared to men. Commonly prescribed drugs for post trauma stress disorder includes antidepressants, sertraline, fluoxetine, paroxetine, and others.

Market Dynamics

Increasing research and development activities by the key market players for the treatment of post-traumatic stress disorder is expected to boost the growth of the global post-traumatic stress disorder treatment market over the forecast period. For instance, in December 2021, Jazz Pharmaceuticals plc. a pharmaceutical company, announced that the company had enrolled its first patient in Phase 2 clinical trial evaluating the safety and efficacy of JZP150, an investigational first-in-class small molecule for the treatment of adults with post-traumatic stress disorder (PTSD). JZP150 is a highly selective inhibitor of the enzyme Fatty Acid Amide Hydrolase (FAAH), designed to address the underlying cause of PTSD (impairment of fear extinction and its consolidation), as well as patient's associated symptoms such as anxiety, insomnia, and nightmares.

Key features of the study:

  • This report provides an in-depth analysis of the global post-traumatic stress disorder treatment market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global post-traumatic stress disorder treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Jazz Pharmaceuticals plc., Madrigal Mental Care, Allergan PLC, Otsuka Pharmaceutical Co., Ltd., apex laboratories Pvt. Ltd., H. Lundbeck A/S (Lundbeck), Neurovation Labs, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Sun Pharmaceuticals Pvt Ltd, Bristol-Myers Squibb, Johnson and Johnson, Pfizer Inc., Aurobindo Inc., Amneal Pharmaceuticals LLC, Teva Pharmaceuticals Industries Ltd., and Mylan Pharmaceuticals (Viatris Inc.)
  • Insights from this report would allow marketers and management authorities of companies to make an informed decision for their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global post-traumatic stress disorder treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global post-traumatic stress disorder treatment market

Detailed Segmentation:

  • Global Post-traumatic Stress Disorder Treatment Market, By Drug Class
    • Antidepressants
    • Anti-anxiety
    • Antihypertensive
    • Monoamine Oxidase (MAOs)
    • Antipsychotics or Second Generation Antipsychotics (SGOs)
    • Beta-Blockers
    • Others (Benzodiazepines and Others)
  • Global Post-traumatic Stress Disorder Treatment Market, By Route of Administration:
    • Oral
    • Parenteral
    • Nasal
  • Global Post-traumatic Stress Disorder Treatment Market, By Age Group:
    • Pediatric
    • Adult
    • Geriatric
  • Global Post-traumatic Stress Disorder Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Post-traumatic Stress Disorder Treatment Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Jazz Pharmaceuticals plc.*
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Madrigal Mental Care
    • Allergan PLC
    • Otsuka Pharmaceutical Co., Ltd.
    • apex laboratories Pvt. Ltd.
    • Lundbeck A/S (Lundbeck)
    • Neurovation Labs, Inc.
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Sun Pharmaceuticals Pvt Ltd
    • Bristol-Myers Squibb
    • Johnson and Johnson
    • Pfizer Inc.
    • Aurobindo Inc.
    • Amneal Pharmaceuticals LLC
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan Pharmaceuticals (Viatris Inc.)

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Age Group
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Post-traumatic Stress Disorder Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • COVID-19 Impact on the market

5. Global Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2017 - 2030, (US$ Million)

  • Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017- 2030
    • Segment Trends
  • Antidepressants
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Anti-anxiety
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Antihypertensive
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Monoamine Oxidase (MAOs)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Antipsychotics or Second Generation Antipsychotics (SGOs)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Beta-Blockers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others (Benzodiazepines and Others)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Post-traumatic Stress Disorder Treatment Market, By Route of Administration, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Parenteral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Nasal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Post-traumatic Stress Disorder Treatment Market, By Age Group, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Pediatric
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Adult
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Geriatric
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Post-traumatic Stress Disorder Treatment Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • Jazz Pharmaceuticals plc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Madrigal Mental Care
    • Allergan PLC
    • Otsuka Pharmaceutical Co., Ltd.
    • apex laboratories Pvt. Ltd.
    • H. Lundbeck A/S (Lundbeck)
    • Neurovation Labs, Inc.
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Sun Pharmaceuticals Pvt Ltd
    • Bristol-Myers Squibb
    • Johnson and Johnson
    • Pfizer Inc.
    • Aurobindo Inc.
    • Amneal Pharmaceuticals LLC
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan Pharmaceuticals (Viatris Inc.)
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About Us